VELCADE TM (bortezomib) for Injection

DRUG2 trials

Sponsors

Millennium Pharmaceuticals, Inc.

Conditions

Mantle Cell LymphomaProstatic Neoplasms

Phase 1

Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer

CompletedNCT00064610

Millennium Pharmaceuticals, Inc.Prostatic Neoplasms

Start: 2002-12-31Target: 102Updated: 2008-02-11

Phase 2

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

CompletedNCT00063713

Millennium Pharmaceuticals, Inc.Mantle Cell Lymphoma

Start: 2003-06-30Target: 152Updated: 2008-02-11